Circadian rhythm as a therapeutic target

被引:268
|
作者
Ruan, Wei [1 ,2 ]
Yuan, Xiaoyi [1 ]
Eltzschig, Holger K. [1 ]
机构
[1] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Anesthesiol, Houston, TX 77030 USA
[2] Cent South Univ, Xiangya Hosp 2, Dept Anesthesiol, Changsha, Peoples R China
基金
中国国家自然科学基金;
关键词
D O I
10.1038/s41573-020-00109-w
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The circadian clock evolved in diverse organisms to integrate external environmental changes and internal physiology. The clock endows the host with temporal precision and robust adaptation to the surrounding environment. When circadian rhythms are perturbed or misaligned, as a result of jet lag, shiftwork or other lifestyle factors, adverse health consequences arise, and the risks of diseases such as cancer, cardiovascular diseases or metabolic disorders increase. Although the negative impact of circadian rhythm disruption is now well established, it remains underappreciated how to take advantage of biological timing, or correct it, for health benefits. In this Review, we provide an updated account of the circadian system and highlight several key disease areas with altered circadian signalling. We discuss environmental and lifestyle modifications of circadian rhythm and clock-based therapeutic strategies, including chronotherapy, in which dosing time is deliberately optimized for maximum therapeutic index, and pharmacological agents that target core clock components and proximal regulators. Promising progress in research, disease models and clinical applications should encourage a concerted effort towards a new era of circadian medicine.
引用
收藏
页码:287 / 307
页数:21
相关论文
共 50 条
  • [1] Circadian rhythm as a therapeutic target
    Wei Ruan
    Xiaoyi Yuan
    Holger K. Eltzschig
    Nature Reviews Drug Discovery, 2021, 20 : 287 - 307
  • [2] Circadian Rhythm: Potential Therapeutic Target for Atherosclerosis and Thrombosis
    Man, Andy W. C.
    Li, Huige
    Xia, Ning
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (02) : 1 - 19
  • [3] PPARα is a potential therapeutic drug target of circadian rhythm sleep disorders
    Oishi, Katsutaka
    Shirai, Hidenori
    Kudo, Takashi
    Shibata, Shigenobu
    Ishida, Norio
    NEUROSCIENCE RESEARCH, 2007, 58 : S48 - S48
  • [4] PPARα is a potential therapeutic target of drugs to treat circadian rhythm sleep disorders
    Shirai, Hidenori
    Oishi, Katsutaka
    Kudo, Takashi
    Shibata, Shigenobu
    Ishida, Norio
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2007, 357 (03) : 679 - 682
  • [5] Circadian rhythm genes contribute to the prognosis prediction and potential therapeutic target in gastric cancer
    Zhang, Chao
    Yin, Wen
    Yuan, Li-Ping
    Xiao, Li-Jun
    Yu, Jing
    Xiao, Wan-Meng
    Luo, Gang
    Deng, Ming-Ming
    Liu, Sha
    Lu, Mu-Han
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [6] Circadian regulators as a therapeutic target in MI
    Fernández-Ruiz I.
    Nature Reviews Cardiology, 2020, 17 (1) : 6 - 6
  • [7] Ticking Brain: Circadian Rhythm as a New Target for Cerebroprotection
    Xu, Shuaili
    Jia, Milan
    Guo, Jiaqi
    He, Jiachen
    Chen, Xi
    Xu, Yi
    Hu, Wenbo
    Wu, Di
    Wu, Chuanjie
    Ji, Xunming
    STROKE, 2024, 55 (09) : 2385 - 2396
  • [8] Circadian Rhythm Gene dec2 Is a Critical Regulator and Potential Therapeutic Target in Pancreatic Cancer Dormancy
    Casabianca, Anthony S.
    Harris, Chris
    Dudgeon, Crissy
    Carpizo, Darren R.
    ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (SUPPL 2) : 385 - 386
  • [9] Abnormal blood pressure circadian rhythm: A target organ damage?
    Izzedine, H
    Launay-Vacher, V
    Deray, G
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2006, 107 (03) : 343 - 349
  • [10] CIRCADIAN-RHYTHM OF THERAPEUTIC EFFECTIVENESS OF OXYMETHOLONE IN PARAPLEGIC PATIENTS
    EDE, MCM
    BURR, RG
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1973, 14 (03) : 448 - 454